Polaris Venture Capital logo

Polaris Venture Capital

Asia, Tel Aviv, Israel, Tel Aviv

Description

PVC is committed to building successful enterprises through value-added partnerships with promising technology companies.

Investor Profile

Polaris Venture Capital has made 18 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (28%)
  • Series Unknown (17%)
  • Seed (11%)
  • Series A (11%)
  • Series C (6%)
  • Series D (6%)
  • Series E (6%)
  • Series G (6%)
  • Private Equity (6%)
  • Pre Seed (6%)

Country Focus

  • United States (89%)
  • Israel (6%)
  • Germany (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Pharmaceutical
  • Therapeutics
  • Audio
  • Consumer Electronics
  • Wireless
  • Medical Device
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Polaris Venture Capital frequently co-invest with?

Viva Ventures Biotech Fund
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
SG
North America, Massachusetts, United States, Stoneham
Co-Investments: 1
Baxter International
North America, Illinois, United States, Deerfield
Co-Investments: 1
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Venture Capital Fund of New England
North America, Massachusetts, United States, Wellesley
Co-Investments: 3
Ascension Ventures
North America, Missouri, United States, Clarkton
Co-Investments: 1
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1

Which angels does Polaris Venture Capital often collaborate with?

Dan Burgess
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Polaris Venture Capital?

Freckle

Cambridge, Massachusetts, United States

Freckle offers a data enrichment and research platform for non-technical users.

Data ManagementSoftware
Pre SeedDec 2, 2024
Amount Raised: $1,900,000
Seraxis

Germantown, Maryland, United States

Seraxis is a privately owned biotechnology company.

BiotechnologyHealth Care
Series CFeb 9, 2021
Amount Raised: $40,000,000
NakedPoppy

San Francisco, California, United States

NakedPoppy is a clean beauty company that curates better-for-you beauty brands and tailors them to you.

BeautyCosmeticsHealth CareWomen's
SeedMar 27, 2019
Amount Raised: $4,087,068
Lyra Therapeutics

Watertown, Massachusetts, United States

Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.

BiotechnologyHealth CarePharmaceuticalTherapeuticsWellness
Series BSep 26, 2018
Amount Raised: $29,500,000
Respicardia

Minnetonka, Minnesota, United States

Respicardia develops implantable therapies to improve respiratory and cardiovascular health.

Health CareMedical DeviceTherapeutics
Series UnknownDec 19, 2017
Amount Raised: $58,500,000
Cardlytics

Atlanta, Georgia, United States

Cardlytics uses purchase-based intelligence to make marketing more relevant and measurable.

AdvertisingBankingFinancial ServicesMobile
Series GMay 18, 2017
Amount Raised: $11,940,331
aTyr Pharma

San Diego, California, United States

aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Series EMar 31, 2015
Amount Raised: $76,000,000
Ocular Therapeutix

Bedford, Massachusetts, United States

Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.

BiotechnologyHealth CareMedical Device
Series DJun 10, 2013
Amount Raised: $23,800,000
Avitide

Lebanon, New Hampshire, United States

Avitide develops affinity purification solutions for biopharmaceutical companies.

BiotechnologyHealth CareLife Science
Series AMar 4, 2013
Amount Raised: $1,440,000
Avila Therapeutics

Waltham, Massachusetts, United States

Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.

BiotechnologyHealth CareMedical
Series BJul 27, 2009
Amount Raised: $30,000,000